1. Home
  2. ETNB vs AMR Comparison

ETNB vs AMR Comparison

Compare ETNB & AMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETNB
  • AMR
  • Stock Information
  • Founded
  • ETNB 2018
  • AMR 2016
  • Country
  • ETNB United States
  • AMR United States
  • Employees
  • ETNB N/A
  • AMR N/A
  • Industry
  • ETNB Biotechnology: Pharmaceutical Preparations
  • AMR Coal Mining
  • Sector
  • ETNB Health Care
  • AMR Energy
  • Exchange
  • ETNB Nasdaq
  • AMR Nasdaq
  • Market Cap
  • ETNB 1.5B
  • AMR 1.5B
  • IPO Year
  • ETNB 2019
  • AMR N/A
  • Fundamental
  • Price
  • ETNB $9.59
  • AMR $134.42
  • Analyst Decision
  • ETNB Strong Buy
  • AMR Buy
  • Analyst Count
  • ETNB 8
  • AMR 3
  • Target Price
  • ETNB $26.43
  • AMR $141.50
  • AVG Volume (30 Days)
  • ETNB 1.5M
  • AMR 461.3K
  • Earning Date
  • ETNB 08-08-2025
  • AMR 08-08-2025
  • Dividend Yield
  • ETNB N/A
  • AMR N/A
  • EPS Growth
  • ETNB N/A
  • AMR N/A
  • EPS
  • ETNB N/A
  • AMR 2.04
  • Revenue
  • ETNB N/A
  • AMR $2,625,170,000.00
  • Revenue This Year
  • ETNB N/A
  • AMR N/A
  • Revenue Next Year
  • ETNB N/A
  • AMR $21.82
  • P/E Ratio
  • ETNB N/A
  • AMR $65.83
  • Revenue Growth
  • ETNB N/A
  • AMR N/A
  • 52 Week Low
  • ETNB $4.16
  • AMR $97.41
  • 52 Week High
  • ETNB $11.84
  • AMR $303.41
  • Technical
  • Relative Strength Index (RSI)
  • ETNB 41.01
  • AMR 61.71
  • Support Level
  • ETNB $9.82
  • AMR $113.78
  • Resistance Level
  • ETNB $10.48
  • AMR $145.42
  • Average True Range (ATR)
  • ETNB 0.49
  • AMR 7.02
  • MACD
  • ETNB -0.14
  • AMR 2.44
  • Stochastic Oscillator
  • ETNB 3.70
  • AMR 69.62

About ETNB 89bio Inc.

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).

About AMR Alpha Metallurgical Resources Inc.

Alpha Metallurgical Resources Inc is a Tennessee-based coal mining company with operations across Virginia and West Virginia. The company's portfolio of mining operations consists of underground mines, surface mines, and coal preparation plants. It produces low-ash metallurgical coal, including High-Vol. A, Mid-Vol., High-Vol. B, and Low-Vol. coal, which is shipped to domestic and international coke and steel producers. The reportable segment of the company is Met. It extracts, processes and markets met and thermal coal from deep and surface mines for sale to steel and coke producers, industrial customers, and electric utilities.

Share on Social Networks: